Article info
PDFConcise report
The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease
- John D Reveille, MD, The University of Texas-Houston Health Science Center, MSB 5.270, 6431 Fannin, Houston, TX 77030, USA; john.d.reveille{at}uth.tmc.edu
Citation
The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease
Publication history
- Accepted October 22, 2007
- First published December 13, 2007.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group and European League Against Rheumatism